Journal Information
Vol. 34. Issue 5.
Pages 329-335 (May 2015)
Share
Share
Download PDF
More article options
Visits
8701
Vol. 34. Issue 5.
Pages 329-335 (May 2015)
Original Article
Open Access
Relationship between severity of pulmonary hypertension and coronary sinus diameter
Relação entre a gravidade da hipertensão pulmonar e o diâmetro do seio coronário
Visits
8701
Mustafa Cetina,
Corresponding author
drmcetin@gmail.com

Corresponding author.
, Musa Cakicia, Cemil Zencirb, Hakan Tasolara, Ercan Cilc, Emrah Yıldızb, Mehmet Ballia, Sabri Abusa, Erdal Akturka
a Adiyaman University, School of Medicine, Department of Cardiology, Adiyaman, Turkey
b Kahramanmaras State Hospital, Department of Cardiology, Kahramanmaras, Turkey
c Adiyaman University, School of Medicine, Department of Pulmonary Medicine, Adiyaman, Turkey
This item has received

Under a Creative Commons license
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Figures (3)
Show moreShow less
Tables (3)
Table 1. Baseline demographic and echocardiographic characteristics of the study population.
Table 2. Right ventricular systolic and diastolic function parameters.
Table 3. Association of mean coronary sinus diameter and other parameters.
Show moreShow less
Abstract
Introduction and Objective

We investigated the relationship between coronary sinus (CS) diameter and pulmonary artery systolic pressure (PASP) in patients with pulmonary hypertension (PH) and normal left ventricular systolic function.

Methods

A total of 155 participants referred for transthoracic echocardiography were included in the study. The study population consisted of 100 patients with chronic PH and 55 control subjects. Patients with PH were divided into two groups according to PASP: those with PASP 36–45 mmHg, the mild PH group (n=53); and those with PASP >45 mmHg, the moderate to severe PH group (n=47). CS diameter was measured from the posterior atrioventricular groove in apical 4-chamber view during ventricular systole according to the formula: mean CS=(proximal CS+mid CS+distal CS)/3.

Results

Mean CS diameter was significantly higher in the moderate to severe PH group than in the controls and in the mild PH group (1.12±0.2 cm vs. 0.82±0.1 cm and 0.87±0.1 cm, respectively; p<0.001). It was significantly correlated with right atrial (RA) area (r=0.674, p<0.001), RA pressure (r=0.458, p<0.001), PASP (r=0.562, p<0.001), inferior vena cava diameter (r=0.416, p<0.001), right ventricular E/A ratio (r=−0.290, p<0.001), and E/Em ratio (r=0.235, p=0.004). RA area (β=0.475, p<0.001) and PASP (β=0.360, p=0.002) were found to be independent predictors of CS diameter.

Conclusions

A dilated CS was associated with moderate to severe pulmonary hypertension, and RA area and PASP were independent predictors of CS diameter.

Keywords:
Pulmonary hypertension
Coronary sinus
Right atrial area
Pulsed-wave tissue Doppler
Resumo
Introdução e objetivos

Os autores analisaram a relação entre o diâmetro do seio coronário (SC) e a pressão sistólica arterial pulmonar (PSAP) em doentes com hipertensão pulmonar (HP) que apresentaram funções sistólicas ventriculares esquerdas normais.

Métodos

Um total de 155 participantes referidos para ecocardiografia transtorácica foram incluídos no estudo. A população do estudo é composta por 100 doentes com HP crónica e 55 indivíduos no grupo controlo. Os doentes com HP foram divididos em dois grupos de acordo com a PSAP. Os doentes que tiveram PSAP de 36 a 45 mmHg foram definidos como o grupo de HP ligeiro (n = 53) e aqueles com PSAP > 45 mmHg foram selecionados como o grupo de HP moderada-grave (n = 47). O diâmetro do SC foi medido desde o sulco auriculoventricular posterior na incidência apical quarto câmaras durante a sístole ventricular de acordo com a fórmula: media do SC = (SC proximal + SC médio + SC distal)/3.

Resultados

O diâmetro médio do SC foi significativamente superior no grupo da HP moderada –grave do que no grupo controlo e no grupo da HP suave (1,12±0,2 cm versus 0,82±0,1 cm e 0,87±0,1 cm; p <0,001, respetivamente). Verificou-se uma correlação, estatisticamente significativa, com a área da aurícula direita (AD) (r = 0,674, p < 0,001), pressão da AD (r = 0,458, p < 0,001), PSAP (R = 0,562, p < 0,001), veia cava inferior (r = 0,416, p < 0,001), rácio ventricular direito E/A (r = −0,290, p < 0,001) e rácio E/Em (r = 0,235, p = 0,004). Área da AD (β = 0,475, p < 0,001) e PSAP (β = 0,360, p = 0,002) foram encontradas como fatores preditores independentes do diâmetro do SC.

Conclusões

O SC dilatado foi associado à hipertensão pulmonar moderada a grave e a área da AD e da PSAP foram fatores preditores independentes do diâmetro do SC.

Palavras-chave:
Hipertensão pulmonar
Seio coronário
Área auricular direita
Doppler tecidular onda de pulso
Full Text
Introduction

Pulmonary hypertension (PH) is routinely diagnosed in cardiology and pulmonary clinics. Chronic PH causes several adaptive changes in the right heart chambers due to pressure overload. Myocardial hypertrophy is the initial adaptive response, followed by progressive contractile dysfunction.1 Chamber dilatation ensues to allow compensatory preload and maintain stroke volume despite reduced fractional shortening. As contractile weakening progresses, clinical evidence of right ventricular (RV) failure occurs, characterized by rising filling pressures, diastolic dysfunction, and diminishing cardiac output.2 As a part of these processes, the inferior vena cava (IVC), which opens into the right atrium (RA), adapts to these changes, which results in reduced collapse with inspiration and dilatation due to pressure overload.

The coronary sinus (CS) is a venous structure that drains myocardial blood primarily from the left ventricle (LV) into the RA, which also receives blood from the IVC. CS diameter has been correlated significantly with pulmonary artery systolic pressure (PASP) in patients with PH resulting from chronic lung disease and LV dysfunction.3 In patients with chronic heart failure (CHF), a dilated CS is possibly a part of the process of cardiac remodeling and may provide useful information to predict the severity of CHF and poor functional class.4 Thus, it is unclear whether the underlying cause of CS dilatation is secondary to PH or a part of cardiac remodeling in patients with CHF.

In our echocardiographic study, we aimed to investigate the relationship between CS diameter and PASP, and to identify predictors of dilated CS in patients with PH.

MethodsStudy patients

This was a cross-sectional clinical study that included 155 participants in stable sinus rhythm prospectively referred for transthoracic echocardiography (TTE). The study population consisted of 100 patients with chronic PH and 55 control subjects. The study was conducted according to the guidelines of the Declaration of Helsinki and was approved by the local Ethics Committee, and informed consent was obtained from all patients.

Patients with a possible diagnosis of PH resulting from thrombotic and/or embolic disease, left ventricular (LV) systolic dysfunction, LV wall motion abnormalities and/or dilatation, more than mild LV diastolic dysfunction,5 more than mild aortic and mitral regurgitation, or any grade of valvular stenosis, severe tricuspid regurgitation, renal dysfunction (serum creatinine >1.5 mg/dl), cirrhotic liver disease, or inadequate imaging of the coronary sinus (CS) and/or IVC were excluded from the study. The subjects were divided into three groups according to PASP: patients with PASP ≤35 mmHg (control group, n=55), those with PASP 36–45 mmHg (mild PH group, n=53) and those with PASP >45 mmHg (moderate to severe PH group, n=47).6,7 PH was defined as values of PASP >35 mmHg.3,6–8

Echocardiographic measurements

TTE was performed in all patients as a part of the normal clinical examination to clarify the etiology of various symptoms such as shortness of breath or asthenia or reduction in functional capacity to exclude cardiovascular and pulmonary disease, and all patients underwent a comprehensive examination, including M-mode, two-dimensional (2D), conventional Doppler and tissue Doppler echocardiography in partial left decubitus using a GE Vivid E9 system (General Electric, Chicago, IL, USA) with a 2.5–3.5 MHz transducer in accordance with the American Society of Echocardiography (ASE)/European Society of Cardiology (ESC) guidelines.7,9,10 All measurements were obtained by two experienced echocardiographers, blinded to clinical information and using the same measurement protocol, and averaged.

PASP was non-invasively estimated with echo Doppler techniques from peak instantaneous systolic pressure drop from the right ventricle (RV) to the right atrium (RA) and RA pressure (RAP). The RV-RA gradient was estimated by the peak velocity of the tricuspid regurgitant flow signal using the simplified Bernoulli equation (continuous-wave Doppler in apical 4-chamber [A4C] view), while RAP was estimated from end-expiratory diameter and respiratory changes in the IVC in subcostal view.11 A normal IVC diameter (≤2.1 cm) and inspiratory collapse of >50% suggests an estimated RAP of 3 mmHg (range, 0–5 mmHg); a normal IVC diameter without inspiratory collapse of >50% and dilatation (>2.1 cm) with inspiratory collapse (>50%) suggests an estimated RAP of 8 mmHg (range, 5–10 mmHg); and dilatation (>2.1 cm) without inspiratory collapse of >50% suggests an estimated RAP of 15 mmHg.7 PASP was estimated by the formula: 4 v2+RAP.12 The degree of tricuspid regurgitation (TR) was graded as mild, moderate or severe. Mild TR was defined as vena contracta width (the narrowest portion of the jet just downstream from the valve orifice on Doppler echo) of <0.3 cm, and severe TR as greater than 0.7 cm. Moderate TR was defined as a vena contracta width of 0.3–0.69 cm.

Left ventricular ejection fraction (LVEF) was measured from A4C view using the modified Simpson's biplane method.9 RV free wall thickness was measured at end-diastole by M-mode echocardiography from the subcostal window, at the level of the tip of the anterior tricuspid leaflet.7

RV end-diastolic and end-systolic area were measured from A4C view using 2D-mode echo7 and fractional area change (FAC) was estimated as (end-diastolic area−end-systolic area)/end-diastolic area×100. Tricuspid annular plane systolic excursion (TAPSE) was measured by positioning the M-mode cursor at the junction of the tricuspid valve (TV) plane with the RV free wall, and was defined as the displacement of the TV plane from end-diastole to end-systole. RV end-diastolic diameters were measured at the inflow tract from A4C view using 2D-mode echo.7 Right atrial (RA) area was estimated by planimetry (Figure 1).7 Body surface area (BSA) was calculated by the Mosteller formula: BSA=square root (height (cm)×weight (kg))/3600.13

Figure 1.

Measurement of right atrial area using the planimetry method from apical 4-chamber view. The green arrow shows this patient's right atrial area.

(0.08MB).

If the transducer is slightly tilted posteriorly to the level of the dorsal wall of the heart in A4C view, the CS and its entry into the RA can be visualized by echocardiography as a sonolucency in the posterior atrioventricular groove. Maximum CS diameter was measured during ventricular systole, since this is when its diameter is at its greatest. Three measurements were obtained, as follows: at the termination of the CS orifice, 1 cm to its left, and between the orifice and the left side origin (Figure 2).4 Mean CS diameter was derived as (proximal CS+mid CS+distal CS)/3. Intra- and interobserver variability were 3.2% and 4.1%, respectively. In order to exclude the existence of a persistent left superior vena cava, agitated saline contrast was injected in a left arm peripheral vein in patients with a large CS (mean diameter >0.8 cm).

Figure 2.

Measurement of coronary sinus (CS) diameter. Three measurements were obtained at the termination of the CS orifice, 1 cm to its left, and between the orifice and the left side origin.

(0.08MB).

To measure RV diastolic function, RV inflow was analyzed using pulsed Doppler in A4C view, positioning the sample volume between the tricuspid leaflets at the middle of the tricuspid annulus. The following measurements of RV global filling were determined: E and A peak velocities (in m/s), E/A ratio, and E-wave deceleration time (DT).7 Tissue Doppler was performed using transducer frequencies of 3.5–4.0 MHz, adjusting the spectral pulsed Doppler signal filters until a Nyquist limit of 15–20 cm/s was reached, and using minimal optimal gain. The pulsed Doppler sample volume was subsequently placed at the level of the lateral tricuspid annulus in A4C view. The tissue Doppler pattern of the mitral annulus is characterized by a positive myocardial systolic wave (Sm) and two negative diastolic waves: early (Em) and atrial (Am). Tissue Doppler systolic indices include myocardial peak velocity of Sm (in cm/s), and diastolic indices include myocardial early (Em) and atrial (Am) peak velocities (in cm/s). The E/Em ratio was also calculated.

Statistical analysis

Continuous data were presented as mean ± SD and categorical data were expressed as numbers and percentages. The Kolmogorov-Smirnov test was used to assess the normality of the distribution of continuous variables. One-way analysis of variance (ANOVA) with the post-hoc Tukey test or the Kruskal-Wallis test was used to compare the three groups. Categorical variables were summarized as percentages and compared with the chi-square test. Correlation analysis was performed using Pearson's and Spearman's correlation tests. To determine independent predictors of dilated CS, multivariate linear regression analysis was performed including age and parameters with p<0.10. A value of p<0.05 was considered statistically significant. Statistical analyses were conducted using Statistical Package for the Social Sciences (SPSS 17) for Windows (SPSS Inc., Chicago, IL, USA).

Results

The etiology of PH was chronic obstructive pulmonary disease in 84 patients (84%), interstitial lung disease in seven (7%), alveolar hypoventilation disorders in four (4%), sleep-disordered breathing in three (3%), and idiopathic in two (2%). The baseline demographic and echocardiographic characteristics of the three groups are listed in Table 1. There were no significant differences between the groups with respect to baseline demographic characteristics, left ventricular 2D, M-mode and pulsed Doppler echocardiographic findings, or LA diameter. Mean PASP, IVC diameter and RAP were significantly different in each group (p<0.001 for all parameters), while mean RA end-systolic area, RV free wall thickness, RV basal diameter, RV end-diastolic and systolic area, and mean CS diameter (Figure 3) were significantly higher in the moderate to severe PH group.

Table 1.

Baseline demographic and echocardiographic characteristics of the study population.

Variable  Groupp (1–2)  p (1–3)  p (2–3) 
  1a (n=55)  2b (n=53)  3c (n=47)       
Age, years  61±13.8  59.9±13.7  65.6±14.6  0.900  0.235  0.106 
Female, n (%)  40 (72.7)  31 (58.5)  32 (68.1)  0.121  0.610  0.324 
Diabetes, n (%)  14 (25.5)  11 (20.8)  12 (25.5)  0.564  0.993  0.573 
HTN, n (%)  18 (32.7)  18 (34)  21 (44.7)  0.892  0.218  0.275 
Smoker, n (%)  11 (20)  11 (20.8)  9 (19.1)  0.923  0.914  0.842 
CAD, n (%)  4 (7.3)  5 (9.4)  5 (10.6)  0.686  0.552  0.842 
BMI (kg/m226.7±3.9  26.9±4.1  26.7±3.5  0.932  0.986  0.871 
BSA (m21.79±0.2  1.81±0.1  1.76±0.2  0.714  0.679  0.255 
LVEF, n (%)  62.3±2.5  63.7±3.6  62.8±3.4  0.081  0.703  0.371 
LVH, n (%)  12 (21.8)  18 (34)  12 (25.5)  0.161  0.661  0.361 
LVEDD (cm)  4.76±0.3  4.78±0.3  4.67±0.3  0.823  0.301  0.128 
LA diameter (cm)  3.58±0.3  3.61±0.4  3.64±0.3  0.913  0.576  0.818 
E/A ratio  0.94±0.2  0.91±0.2  0.93±0.2  0.790  0.994  0.859 
RA end-systolic area (cm214.1±2.1  15.3±4.3  19.4±3.9  0.220  <0.001  <0.001 
RV free wall thickness (cm)  0.55±0.1  0.58±0.1  0.63±0.1  0.173  <0.001  0.036 
RV basal diameter (cm)  3.4±0.2  3.5±0.5  3.8±0.5  0.883  <0.001  0.001 
RV end-diastolic area (cm217±2.3  17.9±2.9  18.8±3.3  0.189  0.005  0.302 
RV end-systolic area (cm28.9±1.2  9.4±2  11±2.6  0.357  <0.001  0.001 
PASP (mmHg)  26.8±3.9  38.1±2.3  49.9±4.9  <0.001  <0.001  <0.001 
RAP (mmHg)  3.3±0.8  4.7±1.9  11.3±4.4  0.028  <0.001  <0.001 
IVC diameter (cm)  1.75±0.2  1.9±0.2  2.2±0.2  <0.001  <0.001  <0.001 
CS mean diameter (cm)  0.82±0.1  0.87±0.1  1.12±0.2  0.306  <0.001  <0.001 
Mild TR, n (%)  44 (80)  32 (60.4)  12 (25.5)  0.026  <0.001  <0.001 
Moderate TR, n (%)  11 (20)  21 (39.6)  35 (74.5)  0.026  <0.001  <0.001 

BMI: body mass index; BSA: body surface area; CAD: coronary artery disease; CS: coronary sinus; HTN: hypertension; IVC: inferior vena cava; LA: left atrial; LV: left ventricular; LVEDD: left ventricular end-diastolic diameter; LVEF: left ventricular ejection fraction; LVH: left ventricular hypertrophy; PASP: pulmonary artery systolic pressure; RA: right atrial; RAP: right atrial pressure; RV: right ventricular; TAPSE: tricuspid annular plane systolic excursion; TR: tricuspid regurgitation.

Data presented as n (%) or mean ± SD.

a

Controls.

b

Mild PH.

c

Moderate to severe PH.

Figure 3.

Error bar graph of mean coronary sinus diameter in the three groups. CI: confidence interval; CS: coronary sinus; PH: pulmonary hypertension.

(0.05MB).

The RV systolic and diastolic function parameters of the study population are shown in Table 2. FAC, TAPSE and Sm wave were significantly decreased in the moderate to severe PH group. Tricuspid inflow A and Am wave were similar between the groups (p>0.05). E wave and E/A ratio were significantly lower in the moderate to severe PH group, whereas E/Em ratio was significantly different in each group (p<0.001), and had the highest value in the moderate to severe PH group.

Table 2.

Right ventricular systolic and diastolic function parameters.

Variable  Groupp (1–2)  p (1–3)  p (2–3) 
  1a (n=55)  2b (n=53)  3c (n=47)       
Systolic function
RV fractional area change (%)  46.9±12  47.6±6.7  40.9±12.5  0.937  0.016  0.006 
TAPSE (cm)  2.7±0.3  2.6±0.4  2.3±0.6  0.881  <0.001  <0.001 
Sm wave (cm/s)  15.3±2.6  14.5±3.1  13.6±3.2  0.391  0.012  0.228 
Diastolic function
E wave (cm/s)  47.1±5.9  46.3±7.4  40.3±8.5  0.856  <0.001  <0.001 
A wave (cm/s)  43.6±4.4  44.7±7  45.2±6.4  0.591  0.359  0.908 
Deceleration time (ms)  186.8±26.2  192.9±33.5  199.3±27  0.523  0.100  0.837 
E/A ratio  1.09±0.2  1.05±0.2  0.90±0.2  0.672  <0.001  <0.001 
Em wave (cm/s)  14.1±2.2  12±2.8  9.1±3.1  0.001  <0.001  <0.001 
Am wave (cm/s)  13.6±2.3  13.7±4.2  14.3±2.6  0.956  0.507  0.685 
E/Em ratio  3.4±0.6  4.1±1.3  4.9±1.8  0.022  <0.001  0.009 

Am: myocardial atrial peak velocity; Em: myocardial early peak velocity; Sm: myocardial systolic wave velocity. Other abbreviations as in Table 1.

Data presented as n (%) or mean ± SD.

a

Controls.

b

Mild PH.

c

Moderate to severe PH.

In the correlation analysis, mean CS diameter was significantly correlated with RA area, FAC, RAP, PASP, IVC, LA diameter, right ventricular E/A ratio, DT, Sm wave and E/Em ratio (Table 3). To find independent predictors of CS diameter, a multivariate regression model including age, FAC, RA area, RAP, PASP, moderate TR, IVC, right ventricular E/A ratio, DT, Sm wave and E/Em ratio was constructed. There was no multicollinearity between the selected parameters in the collinearity statistics (lowest tolerance value >0.2). In multivariate analysis, RA area (β=0.475, p<0.001) and PASP (β=0.360, p=0.002) were found to be independent predictors of CS diameter.

Table 3.

Association of mean coronary sinus diameter and other parameters.

Variables 
Age  0.141  0.079 
LA diameter  0.051  0.527 
LVEDD  −0.126  0.118 
LVEF  −0.030  0.708 
BMI  −0.024  0.769 
RV end-systolic area  0.126  0.118 
RV end-diastolic area  0.034  0.675 
RV fractional area change  −0.270  0.001 
RA end-systolic area  0.674  <0.001 
RAP  0.458  <0.001 
PASP  0.562  <0.001 
IVC  0.416  <0.001 
TAPSE  −0.043  0.592 
Right ventricular parameters
E/A ratio  −0.290  <0.001 
Deceleration time  0.214  0.007 
Sm  −0.186  0.021 
E/Em ratio  0.232  0.004 

Em: myocardial early peak velocity; Sm: myocardial systolic wave velocity. Other abbreviations as in Table 1.

Discussion

To the best of our knowledge, this is the first study investigating the relationship between CS diameter and both RV systolic and diastolic function in patients with PH. The main findings of our study were as follows: (1) as distinct from previous studies, the novel finding was that CS diameter was significantly increased only in patients with moderate to severe PH; (2) CS diameter was correlated with RA area, PASP, RAP, and both RV systolic (FAC, Sm wave) and diastolic parameters (E/A ratio, DT, E/Em ratio); (3) multivariate analysis determined that RA area and PASP were independent predictors of CS diameter.

The CS is a venous structure located in the posterior groove between the LA and LV. It begins as a continuation of the great cardiac vein and opens into the RA between the IVC and the atrioventricular groove. Its branches include the great, small and middle cardiac veins, as well as the posterior vein of the LV. Although it is easy to visualize, assessment of the CS has been overlooked in routine echocardiographic examination. In patients with CHF, Yuce et al.4 demonstrated that CS dilatation may be a part of the cardiac remodeling process, predicting the severity of chronic heart failure and poor functional capacity. Lee et al.14 found a significant correlation between CS diameter and PASP in a study of patients referred for cardiac resynchronization therapy. There have been few studies investigating the association between CS size and PASP in patients with PH according to our literature search. Mahmud et al.15 reported a positive correlation of CS diameter with RA size and RA pressure in patients who underwent echocardiography and right heart catheterization. In a similar population, Isaacs et al.16 investigated the relationship between CS dilatation and pulmonary artery (PA) pressures using chest computed tomography (CT). Right heart catheterization was also performed to obtain right-sided pressures in the study population. They reported that CS dilation was associated with increased PA pressures in patients with PH. Gunes et al.3 reported that CS diameter was increased in patients with PH and significantly correlated with PASP, RAP, right-heart chamber volumes, LVEF, and IVC diameter. In contrast to our work, these study populations included patients with PH due to left-sided heart disease and lung disease, and they did not investigate RV diastolic function. All of these studies examined CS dilatation, although whether the cause of CS dilatation was secondary to increased PASP or a part of cardiac remodeling in patients with CHF remains unclear due to the heterogeneity of the study populations. To address this in our study, we excluded patients with PH resulting from left heart disease. In PH patients with normal LV size and function, mean CS diameter was found to be significantly increased only in patients with moderate to severe PH, and was correlated with PASP, RAP, RA area, and both RV systolic and diastolic function.

CS size and morphology have also been investigated in patients with supraventricular tachycardia and connection of a persistent left superior vena cava to the CS.17–19 Recently, Vatankulu et al.20 reported that the RV myocardial performance index, which represents both systolic and diastolic function, was increased in patients with mitral stenosis and correlated with CS dilatation. In our literature review, we found no studies investigating the relationship between CS diameter and RV diastolic function in patients with PH. However, we determined that CS dilatation was significantly correlated with RV systolic (FAC, Sm wave) and diastolic parameters (E/A ratio, DT, E/Em ratio).

The ASE/ESC guidelines for the echocardiographic assessment of the right heart in adults9 recommend that RA area should be estimated in patients undergoing assessment of RV or LV dysfunction. Although the RA can be assessed from many different views, quantification of RA size is most commonly performed in A4C view.9 Because of the paucity of standardized RA volume data by 2D echocardiography, routine RA volume measurements are not currently recommended.7 It has been shown that RA area, volume and systolic function increase prior to the development of RV dilatation and systolic dysfunction during chronic pressure overload exposure in PH.21 However, RA volume assessment has not been standardized in the same way as LA volume assessment. In our study, RA area was found to be an independent predictor of a dilated CS rather than RAP, which was indirectly calculated by means of the IVC collapsibility index using echocardiography as in clinical practice. In our view, as RAP can fluctuate over time, RA size may be a better measure of mean RAP and CS dilatation. This may explain why RAP did not remain a significant factor in multivariate regression analysis and suggests that increased RA area and impaired venous drainage secondary to increased PASP may lead to CS dilatation in patients with PH.

Limitations

This was a case-controlled study with a relatively small number of patients. PH is defined as mean pulmonary artery pressure exceeding 25 mmHg at rest as measured by right heart catheterization (RHC).22 However, echocardiography was used in our study to estimate PASP rather than the gold standard of RHC; we could not perform RHC due to ethical concerns. Despite doubts regarding Doppler-derived measurements of PASP,22,23 it can provide an estimate of PASP since it is a readily available and reliable method for serial measurements8 and remains the most effective non-invasive screening tool for the assessment of PH in a clinical setting.24 Additionally, it has been reported that echocardiographic evidence of PH is associated with reduced survival.25

Conclusion

In this study, we determined that mean CS diameter was only increased significantly in patients with moderate to severe PH, and that RA area and PASP were independent predictors of CS diameter in patients with PH. Our data suggest that increased RA area and impaired venous drainage secondary to increased PASP may lead to CS dilatation in patients with PH. Further studies are needed to support these findings.

Ethical disclosuresProtection of human and animal subjects

The authors declare that no experiments were performed on humans or animals for this study.

Confidentiality of data

The authors declare that no patient data appear in this article.

Right to privacy and informed consent

The authors declare that no patient data appear in this article.

Conflicts of interest

The authors have no conflicts of interest to declare.

References
[1]
C.A. Dias, R.S. Assad, L.F. Caneo, et al.
Reversible pulmonary trunk banding. II. An experimental model for rapid pulmonary ventricular hypertrophy.
J Thorac Cardiovasc Surg, 124 (2002), pp. 999-1006
[2]
E.P. Chen, D.M. Craig, H.B. Bittner, et al.
Pharmacological strategies for improving diastolic dysfunction in the setting of chronic pulmonary hypertension.
Circulation, 97 (1998), pp. 1606-1612
[3]
Y. Gunes, U. Guntekin, M. Tuncer, et al.
Association of coronary sinus diameter with pulmonary hypertension.
Echocardiography, 25 (2008), pp. 935-940
[4]
M. Yuce, V. Davutoglu, S. Yavuz, et al.
Coronary sinus dilatation is associated with left ventricular systolic dysfunction and poor functional status in subjects with chronic heart failure.
Int J Cardiovasc Imaging, 26 (2010), pp. 541-545
[5]
M.M. Redfield, S.J. Jacobsen, J.C. Burnett Jr., et al.
Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic.
JAMA, 289 (2003), pp. 194-202
[6]
N. Collins, B. Bastian, L. Quiqueree, et al.
Abnormal pulmonary vascular responses in patients registered with a systemic autoimmunity database: Pulmonary Hypertension Assessment and Screening Evaluation using stress echocardiography (PHASE-I).
Eur J Echocardiogr, 7 (2006), pp. 439-446
[7]
L.G. Rudski, W.W. Lai, J. Afilalo, et al.
Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography.
J Am Soc Echocardiogr, 23 (2010), pp. 685-713
[8]
L.S. Howard, J. Grapsa, D. Dawson, et al.
Echocardiographic assessment of pulmonary hypertension: standard operating procedure.
Eur Respir Rev, 21 (2012), pp. 239-248
[9]
R.M. Lang, M. Bierig, R.B. Devereux, et al.
Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology.
J Am Soc Echocardiogr, 18 (2005), pp. 1440-1463
[10]
S.F. Nagueh, C.P. Appleton, T.C. Gillebert, et al.
Recommendations for the evaluation of left ventricular diastolic function by echocardiography.
Eur J Echocardiogr, 10 (2009), pp. 165-193
[11]
M. Pepi, G. Tamborini, C. Galli, et al.
A new formula for echo-Doppler estimation of right ventricular systolic pressure.
J Am Soc Echocardiogr, 7 (1994), pp. 20-26
[12]
N. Galiè, A. Torbicki, R. Barst, et al.
Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology.
Eur Heart J, 25 (2004), pp. 2243-2278
[13]
R.D. Mosteller.
Simplified calculation of body surface area.
N Engl J Med, 317 (1987), pp. 1098
[14]
M.S. Lee, A.P. Shah, N. Dang, et al.
Coronary sinus is dilated and outwardly displaced in patients with mitral regurgitation: quantitative angiographic analysis.
Catheter Cardiovasc Interv, 67 (2006), pp. 490-494
[15]
E. Mahmud, A. Raisinghani, S. Keramati, et al.
Dilation of the coronary sinus on echocardiogram: prevalence and significance in patients with chronic pulmonary hypertension.
J Am Soc Echocardiogr, 14 (2001), pp. 44-49
[16]
D. Isaacs, S. Hazany, A. Gamst, et al.
Evaluation of the coronary sinus on chest computed tomography in patients with and without pulmonary artery hypertension.
J Comput Assist Tomogr, 33 (2009), pp. 513-516
[17]
M.G. Ong, P.C. Lee, C.T. Tai, et al.
Coronary sinus morphology in different types of supraventricular tachycardias.
J Interv Card Electrophysiol, 15 (2006), pp. 21-26
[18]
Y. Okumura, I. Watanabe, T. Yamada, et al.
Comparison of coronary sinus morphology in patients with and without atrioventricular nodal reentrant tachycardia by intracardiac echocardiography.
J Cardiovasc Electrophysiol, 15 (2004), pp. 269-273
[19]
B.C. Kolski, B. Khadivi, M. Anawati, et al.
The dilated coronary sinus: utility of coronary sinus cross- sectional area and eccentricity index in differentiating right atrial pressure overload from persistent left superior vena cava.
Echocardiography, 28 (2011), pp. 829-832
[20]
M.A. Vatankulu, F. Koc, E.E. Gul, et al.
The relationship between coronary sinus and impaired right ventricular myocardial performance index in mitral stenosis.
Echocardiography, 30 (2013), pp. 936-939
[21]
G. Cioffi, G. de Simone, G. Mureddu, et al.
Right atrial size and function in patients with pulmonary hypertension associated with disorders of respiratory system or hypoxemia.
Eur J Echocardiogr, 8 (2007), pp. 322-331
[22]
N. Galiè, M.M. Hoeper, M. Humbert, et al.
Guidelines for the diagnosis and treatment of pulmonary hypertension.
Eur Respir J, 34 (2009), pp. 1219-1263
[23]
M.R. Fisher, P.R. Forfia, E. Chamera, et al.
Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension.
Am J Respir Crit Care Med, 179 (2009), pp. 615-621
[24]
M.M. Hoeper, J.A. Barberà, R.N. Channick, et al.
Diagnosis, assessment, and treatment of non-pulmonary arterial hypertension pulmonary hypertension.
J Am Coll Cardiol, 54 (2009), pp. S85-S96
[25]
A.C. Stone, J.T. Machan, J. Mazer, et al.
Echocardiographic evidence of pulmonary hypertension is associated with increased 1-year mortality in patients admitted with chronic obstructive pulmonary disease.
Copyright © 2014. Sociedade Portuguesa de Cardiologia
Download PDF
Idiomas
Revista Portuguesa de Cardiologia (English edition)
Article options
Tools
en pt

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

By checking that you are a health professional, you are stating that you are aware and accept that the Portuguese Journal of Cardiology (RPC) is the Data Controller that processes the personal information of users of its website, with its registered office at Campo Grande, n.º 28, 13.º, 1700-093 Lisbon, telephone 217 970 685 and 217 817 630, fax 217 931 095, and email revista@spc.pt. I declare for all purposes that the information provided herein is accurate and correct.